Capital Flow Monitor · Sponsors · CIK 1968662
T.Rx Capital Fund I, LP
135 Seaport Blvd, Boston, MA, 02210 · 617-543-8698
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2023
Fit score
—
Offering
$175.0M
Sold
$77.2M
% sold
44.1%
Investors
48
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-17 | D/A ·current | 506(b) | $175.0M | $77.2M | 44.1% | 48 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A T. Rx Capital Fund I GP, LLC — Executive Officer, Boston, MA
- Michael Langer — Executive Officer, Boston, MA
-
Kwesi Frimpong-Boateng — Executive Officer, Boston, MA
1 other raise
- Antigenix Therapeutics, Inc. $3.4M of $8.4M · 40.2%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.